- Home
- CASS vs IMTX Comparison
CASS vs IMTX Comparison
Compare CASS & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASS
- IMTX
- Stock Information
- Founded
- CASS 1906
- IMTX N/A
- Country
- CASS United States
- IMTX Germany
- Employees
- CASS N/A
- IMTX N/A
- Industry
- CASS Business Services
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CASS Consumer Discretionary
- IMTX Health Care
- Exchange
- CASS Nasdaq
- IMTX Nasdaq
- Market Cap
- CASS 567.9M
- IMTX 653.9M
- IPO Year
- CASS 1996
- IMTX N/A
- Fundamental
- Price
- CASS $39.63
- IMTX $6.48
- Analyst Decision
- CASS Buy
- IMTX Strong Buy
- Analyst Count
- CASS 2
- IMTX 4
- Target Price
- CASS $48.00
- IMTX $14.67
- AVG Volume (30 Days)
- CASS 64.8K
- IMTX 400.5K
- Earning Date
- CASS 07-17-2025
- IMTX 08-12-2025
- Dividend Yield
- CASS 3.13%
- IMTX N/A
- EPS Growth
- CASS N/A
- IMTX N/A
- EPS
- CASS 1.86
- IMTX N/A
- Revenue
- CASS $219,841,000.00
- IMTX $155,801,989.00
- Revenue This Year
- CASS N/A
- IMTX N/A
- Revenue Next Year
- CASS $7.81
- IMTX $1.92
- P/E Ratio
- CASS $25.13
- IMTX N/A
- Revenue Growth
- CASS 2.79
- IMTX 93.56
- 52 Week Low
- CASS $37.99
- IMTX $3.30
- 52 Week High
- CASS $47.14
- IMTX $13.09
- Technical
- Relative Strength Index (RSI)
- CASS 28.39
- IMTX 60.48
- Support Level
- CASS $41.14
- IMTX $6.44
- Resistance Level
- CASS $42.34
- IMTX $6.80
- Average True Range (ATR)
- CASS 1.21
- IMTX 0.32
- MACD
- CASS -0.51
- IMTX 0.02
- Stochastic Oscillator
- CASS 11.60
- IMTX 70.72
About CASS Cass Information Systems Inc
Cass Information Systems Inc is a provider of payment and information processing services to large manufacturing, distribution and retail enterprises across the United States. The company provides transportation invoice rating, payment processing, auditing, accounting, and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility-related expenses. It operates in two segments: Information Services and Banking Services. The firm generates maximum revenue from the Information Services segment, which provides transportation, energy, telecommunication, and environmental invoice processing and payment services to large corporations.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.